Does DULAGLUTIDE Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with DULAGLUTIDE (Trulicity). This represents 0.0% of all adverse event reports for DULAGLUTIDE.
10
Reports of Malignant neoplasm progression with DULAGLUTIDE
0.0%
of all DULAGLUTIDE reports
5
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DULAGLUTIDE?
Of the 10 reports, 5 (50.0%) resulted in death, 1 (10.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULAGLUTIDE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does DULAGLUTIDE Cause?
Injection site pain (9,474)
Nausea (9,137)
Blood glucose increased (9,119)
Incorrect dose administered (5,207)
Diarrhoea (5,036)
Vomiting (4,880)
Inappropriate schedule of product administration (3,606)
Extra dose administered (3,047)
Injection site haemorrhage (3,028)
Weight decreased (3,000)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DULAGLUTIDE Alternatives Have Lower Malignant neoplasm progression Risk?
DULAGLUTIDE vs DULERA
DULAGLUTIDE vs DULOXETINE
DULAGLUTIDE vs DUPILUMAB
DULAGLUTIDE vs DURAGESIC
DULAGLUTIDE vs DUROGESIC